nodes	percent_of_prediction	percent_of_DWPC	metapath
Saprisartan—AGTR1—Arf6 trafficking events—VAMP3—Crohn's disease	0.197	0.197	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—LRRK2—Crohn's disease	0.0429	0.0429	CbGpPWpGaD
Saprisartan—AGTR1—Peptide GPCRs—CCR9—Crohn's disease	0.0413	0.0413	CbGpPWpGaD
Saprisartan—AGTR1—Arf6 trafficking events—ITGA4—Crohn's disease	0.0302	0.0302	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.0296	0.0296	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—MLN—Crohn's disease	0.0284	0.0284	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.028	0.028	CbGpPWpGaD
Saprisartan—AGTR1—Peptide GPCRs—CCR6—Crohn's disease	0.0274	0.0274	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.0254	0.0254	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0231	0.0231	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL17A—Crohn's disease	0.0225	0.0225	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL12B—Crohn's disease	0.0209	0.0209	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.0198	0.0198	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.0194	0.0194	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.0188	0.0188	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—GPR65—Crohn's disease	0.0183	0.0183	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.0164	0.0164	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL10—Crohn's disease	0.0153	0.0153	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.0152	0.0152	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—ACKR2—Crohn's disease	0.0151	0.0151	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—MLN—Crohn's disease	0.0143	0.0143	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.0141	0.0141	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL2RA—Crohn's disease	0.0136	0.0136	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.013	0.013	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.0129	0.0129	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.0121	0.0121	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.0101	0.0101	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CCR9—Crohn's disease	0.00992	0.00992	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00945	0.00945	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—GPR65—Crohn's disease	0.00922	0.00922	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IFNG—Crohn's disease	0.009	0.009	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00887	0.00887	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00863	0.00863	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00845	0.00845	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—Crohn's disease	0.0084	0.0084	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—CXCL8—Crohn's disease	0.00837	0.00837	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—MLN—Crohn's disease	0.00809	0.00809	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL1B—Crohn's disease	0.00803	0.00803	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—ACKR2—Crohn's disease	0.00775	0.00775	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.0076	0.0076	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—MLN—Crohn's disease	0.00734	0.00734	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CCR6—Crohn's disease	0.00657	0.00657	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—TNF—Crohn's disease	0.00582	0.00582	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—PTGER4—Crohn's disease	0.00579	0.00579	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CCR9—Crohn's disease	0.00561	0.00561	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GPR65—Crohn's disease	0.00521	0.00521	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CCR9—Crohn's disease	0.00509	0.00509	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GPR65—Crohn's disease	0.00473	0.00473	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ACKR2—Crohn's disease	0.00458	0.00458	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MLN—Crohn's disease	0.00434	0.00434	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00431	0.00431	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00415	0.00415	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00411	0.00411	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TAGAP—Crohn's disease	0.00397	0.00397	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CCR6—Crohn's disease	0.00371	0.00371	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RSPO3—Crohn's disease	0.00347	0.00347	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CCR6—Crohn's disease	0.00337	0.00337	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SEL1L—Crohn's disease	0.00329	0.00329	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00327	0.00327	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCR9—Crohn's disease	0.00301	0.00301	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PTGER4—Crohn's disease	0.00297	0.00297	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GPR65—Crohn's disease	0.0028	0.0028	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—IL3—Crohn's disease	0.00278	0.00278	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00278	0.00278	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00269	0.00269	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—IL3—Crohn's disease	0.00253	0.00253	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—RASGRP1—Crohn's disease	0.00245	0.00245	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CXCL8—Crohn's disease	0.00212	0.00212	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.00211	0.00211	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCR6—Crohn's disease	0.00199	0.00199	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—IL2RA—Crohn's disease	0.00195	0.00195	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RBX1—Crohn's disease	0.0018	0.0018	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—IL2RA—Crohn's disease	0.00177	0.00177	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PTGER4—Crohn's disease	0.00175	0.00175	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—UBE2D1—Crohn's disease	0.00158	0.00158	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RIPK2—Crohn's disease	0.00153	0.00153	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IL3—Crohn's disease	0.00149	0.00149	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RASGRP1—Crohn's disease	0.00144	0.00144	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—JAK2—Crohn's disease	0.00131	0.00131	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SOCS1—Crohn's disease	0.00131	0.00131	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—TYK2—Crohn's disease	0.00125	0.00125	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CXCL8—Crohn's disease	0.0012	0.0012	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—JAK2—Crohn's disease	0.00119	0.00119	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SMAD3—Crohn's disease	0.00113	0.00113	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CXCL8—Crohn's disease	0.00109	0.00109	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IL2RA—Crohn's disease	0.00105	0.00105	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TYK2—Crohn's disease	0.000737	0.000737	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—JAK2—Crohn's disease	0.000703	0.000703	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CXCL8—Crohn's disease	0.000642	0.000642	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—IL6—Crohn's disease	0.00061	0.00061	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—STAT3—Crohn's disease	0.000516	0.000516	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IL6—Crohn's disease	0.000361	0.000361	CbGpPWpGaD
